Rafael
RFL | NYSE
$0.97
-$0.10 (-9.35%)
At close: Nov 16, 2026, 4:00 PM ET
$0.97
$0.00 (+0.01%)
After-hours:
Nov 16, 2026, 4:00 PM ET
Rafael Company Profile
Company profile explainedCompany Profile
Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Key Executives
| Name | Position |
|---|---|
| Howard S. Jonas | Chief Executive Officer, President, Founder & Executive Chairman |
| David A. Polinsky | Chief Financial Officer |
| Joshua Fine | Chief Operating Officer |
| Joyce J. Mason | Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2026 | 10-K | Annual Report |
| Oct 29, 2026 | 8-K | Current Report |
| Oct 27, 2026 | 4 | Filing |
| Sep 30, 2026 | 8-K | Current Report |
| Sep 23, 2026 | 4 | Filing |
| Jul 31, 2026 | 4 | Filing |
| Jul 08, 2026 | 8-K | Current Report |
| Jun 23, 2026 | 4 | Filing |
| Jun 16, 2026 | 4 | Filing |
| Jun 11, 2026 | 10-Q | Quarterly Report |
Rafael
| Country | United States |
| IPO Date | Mar 27, 2018 |
| Industry | Real Estate - Services |
| Sector | Real Estate |
| Employees | 21 |
| CEO | Howard S. Jonas |
Contact Details
520 Broad Street Newark,
New Jersey 07102 United States
Stock Details
| Ticker Symbol | RFL |
| Exchange | NYSE |
| Fiscal Year | August - July |
| Reporting Currency | USD |
| CIK Code | 0001713863 |
| CUSIP Number | 75062E106 |
| ISIN Number | US75062E1064 |
| SIC Code |
Add to Watchlist
Select watchlists to add or remove RFL